SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mammon who wrote (11370)6/26/2012 10:32:13 AM
From: NTTG1 Recommendation  Respond to of 13111
 
sorry the results didn't turn out the way you wanted, what can I say



To: Mammon who wrote (11370)6/26/2012 10:38:25 AM
From: Mammon1 Recommendation  Read Replies (1) | Respond to of 13111
 
Its interesting, the extraordinary OR in phase III patients. One could make a potent case for injecting it in phase I patients, given the immune system effects and side effect profile, before removing the tumors surgically.